Blue Cross Arizona Reverses HIV Drug Coverage Cut
The insurer will keep covering Biktarvy and other currently covered HIV medications after notifying some ACA members of changes.
Updated on Nov. 20, 2026 in Industry

Blue Cross Blue Shield of Arizona notified some Affordable Care Act members it would no longer cover certain HIV treatments, including single tablet regimens. The insurer later reversed course and said it will continue coverage of all HIV medications currently covered, including Biktarvy.
Why it matters
Some patients were told they could face costs of $3,000 to $4,000 per month for HIV medications, a burden that could have disrupted treatment for people in Arizona. The reversal affects how insurers in the state handle formulary changes for chronic conditions that require consistent, long-term medication.
Patients were initially told they could pay $3,000 to $4,000 per month for HIV medications after the coverage change. The source does not report how many members received the original notices or how many would have been affected.
The players
Blue Cross Blue Shield of Arizona
The Arizona arm of the Blue Cross Blue Shield network, one of the largest health insurers in the state, which reversed its plan to drop coverage of certain HIV medications for ACA members.
Blue Cross Blue Shield of Mississippi
The Mississippi arm of the Blue Cross Blue Shield network, which was accused over the summer of limiting certain HIV drugs.
The details
Patients received notices from their insurer stating certain HIV treatments and prevention drugs would no longer be covered. After further review, Blue Cross Blue Shield of Arizona decided to maintain coverage of Biktarvy and all other HIV medications currently covered, and members previously notified of a Biktarvy change will receive updated information.
Timeline
Summer 2026: Blue Cross Blue Shield of Mississippi was accused of limiting certain HIV drugs.
Earlier in November 2026: Blue Cross Blue Shield of Arizona announced it would stop covering certain HIV treatments.
November 20, 2026: Blue Cross Blue Shield of Arizona reversed its decision.
2027: Biktarvy coverage will be maintained on the ACA formulary.
Healthcare Landscape
The Arizona reversal follows a similar accusation earlier in 2026 against Blue Cross Blue Shield of Mississippi over limits on certain HIV drugs. Together the two cases point to ongoing scrutiny of how Blue Cross plans manage formularies for chronic conditions.
Patients taking Biktarvy or other covered HIV medications in Arizona can continue their current treatment without a coverage change under the reversal. Members who received an earlier notice should watch for updated information from their insurer about their specific plan.
The takeaway
Members who received an earlier Biktarvy coverage notice should check for updated information from their plan. Keeping an active record of your current medications and coverage status can help you respond quickly to future formulary changes.
Further reading
Explore more reporting on Healthcare coverage decisions affecting patients across Arizona.
Source note: This article includes information reported by KJZZ.






